Skip to content
MarketScale
‹ Back to IndustriesHealthcare

HBMA Put Community First During the Pandemic. Here’s How It Paid Off.

Tradeshows are back, baby! Though some are getting cancelled, others persist; here in Dallas, HBMA’s 2021 Healthcare Revenue Cycle Conference brought industry leaders back together to knock heads on healthcare’s major transformations over the last year, and how everything from telemedicine, to alternative insurance plans, to demand for traveling nurses is intersecting with healthcare’s flow…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Tradeshows are back, baby! Though some are getting cancelled, others persist; here in Dallas, HBMA’s 2021 Healthcare Revenue Cycle Conference brought industry leaders back together to knock heads on healthcare’s major transformations over the last year, and how everything from telemedicine, to alternative insurance plans, to demand for traveling nurses is intersecting with healthcare’s flow of dollars.

MarketScale’s healthcare industry lead, David Kemp, hit the show floor to learn more about what’s keeping this side of the healthcare industry strong and innovative. First, we spoke with a trio of thought leaders: Kurt Gallagher, Executive Director of HBMA; Andrew Norrie, Director of Sales for Pettigrew Medical, and Emily M. Osetek, COO of Pettigrew Medical and President of HBMA, to talk “community” in the healthcare business sector, and how HBMA’s strategies to maintaining communications with industry leaders have paid off.

We also got to hear from Eric Christensen; Owner/Co-Founder of HCP (Healthcare Compliance Pros), on their partnership with the HBMA. Since 2017, Eric and the HCP team have worked with HBMA to build an accreditation program to validate the RCM sector within healthcare business management, developing tools for standardized, to create accountability and self-accountability. Here’s why this partnership has been proving useful for professionals in the industry, especially since the global pandemic.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The article discusses the advancements in healthcare with a focus on virtual care, AI, and access, featuring insights from Dr. Geoffrey Rutledge. It explores how these technologies are shaping the future of healthcare delivery. The conversation touches upon the impact on patient care and the potential for improved healthcare accessibility.

  • 01Virtual care and AI are transforming healthcare.
  • 02These technologies enhance patient accessibility and care.
  • 03Healthcare delivery is continuously evolving with new innovations.

Jul 14, 2026

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512